Coronavirus Puts The Brakes On Mylan-Upjohn Merger

Shareholders Meeting In The Netherlands Also Pushed Back

 
• By Dean Rudge
Delayed
Mylan and Pfizer's Upjohn had forecasted pro forma sales of up to $20bn this year • Source: Shutterstock

More from Deals

More from Business